Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TYR | P14679 | 2/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | HTT | P42858 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.33 |
| ▸ | ACR | P10323 | 1/20 | 0.33 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.33 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.33 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.33 |
| ▸ | CA2 | P00918 | 1/20 | 0.31 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5162267 | 0.82 | HSD17B10 (0.42) | KDM4EMEN1HPGDKMT2ASLC6A2 | |
| SCHEMBL5164349 | 0.79 | POLB (0.45) | MEN1ALDH1A1MAPTHTTKMT2A | |
| SCHEMBL5162216 | 0.79 | SLC6A2 (0.40) | SLC6A2SLC6A4SLC6A3CA2OPRK1 | |
| SCHEMBL5164671 | 0.78 | POLB (0.35) | MEN1ALDH1A1MAPTHPGDKMT2A | |
| SCHEMBL5162643 | 0.77 | CYP1A2 (0.45) | TYRHTT | |
| SCHEMBL5159578 | 0.75 | HDAC1 (0.34) | KDM4EALDH1A1HPGDSLC6A2SLC6A4 | |
| SCHEMBL5270844 | 0.73 | CYP3A4 (0.39) | KDM4EMEN1ALDH1A1LMNAHPGD | |
| SCHEMBL5162258 | 0.72 | MEN1 (0.45) | MEN1ALDH1A1LMNAKMT2A | |
| SCHEMBL29221773 | 0.71 | EGFR (0.49) | MEN1ALDH1A1LMNAHPGDKMT2A | |
| SCHEMBL5162141 | 0.71 | CA2 (0.50) | MEN1ALDH1A1KMT2ANPSR1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070067922-A1 | 4-Aminophenol derivatives and colorants comprising these compounds | PROCTER & GAMBLE COMPANY, THE | 2007-03-29 | — | — | US | claimed |
| EP-1762218-A1 | 4-aminophenol derivatives and colorants comprising these compounds | Wella Aktiengesellschaft (DE) | 2007-03-14 | — | — | EP | claimed |
| WO-2007026313-A2 | 4-AMINOPHENOL DERIVATIVES AND COLORANTS COMPRISING THESE COMPOUNDS | THE PROCTER & GAMBLE COMPANY (US) | 2007-03-08 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070067922-A1 | 4-Aminophenol derivatives and colorants comprising these compounds | KRT18, S100A4, CKAP4 | TYR 26/4885KDM4E 251/4885MEN1 4874/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.